{"id":"NCT04029519","sponsor":"Prollenium Medical Technologies Inc.","briefTitle":"A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation","officialTitle":"A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-12-21","primaryCompletion":"2019-08-27","completion":"2019-08-27","firstPosted":"2019-07-23","resultsPosted":"2021-07-14","lastUpdate":"2021-07-14"},"enrollment":84,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Lip Augmentation"],"interventions":[{"type":"DEVICE","name":"PN40082","otherNames":[]}],"arms":[{"label":"PN40082","type":"EXPERIMENTAL"}],"summary":"To evaluate the safety and efficacy of retreatment with PN40082 for lip augmentation.","primaryOutcome":{"measure":"Change From Baseline in Lip Fullness Grading Scale","timeFrame":"Visit 1/Day 1 to Visit 3/Month 2, 56 Days","effectByArm":[{"arm":"PN40082","deltaMin":0.82,"sd":0.747}],"pValues":[]},"eligibility":{"minAge":"21 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":84},"commonTop":["Injection Site Swelling","Injection Site Bruising","Injection site pain","Injection Site Erythema","Injection site mass"]}}